Using Embolic Glass Microspheres to Target Chronic Disease
Sierra Kucko
•
February 5, 2025
Glass
microspheres under magnification. Image source: MO SCI.
Glass Microspheres: The Tiny Superheroes of Glass Form
Factors
Two main factors contribute to the properties of glass:
composition and form factor. While emphasis is often placed on glass
composition, the form factor is arguably equal in importance. Glass in the form
of microspheres has permeated various industries, ranging from aerospace to
medical sectors. MO SCI specializes in the production of precision glass
microspheres that have become invaluable to these industries, and
their usage is ever-evolving. Whether it be controlling gaps for adhesive
bondline spacing, improving the visibility of road markings, or drug delivery
devices, glass microspheres fit the bill.
Targeted Treatment with Embolic Glass Microspheres
Biocompatible (and
in some cases biodegradable) microspheres are especially appreciated for
medical applications, such as transarterial embolization (TEA) or
musculoskeletal (MSK) embolization.1,2
TEA refers to the blockage of blood supply, which may sound
like a bad thing, but in many cases, these are lifesaving procedures. For
example, a substantial driver for this technology is cancer treatment. One way
to combat a tumor or abnormal tissue growth is to cut off its blood supply,
which can be achieved through the precise application of appropriately sized
microspheres to occlude the fine vasculature ‘feeding’ it.1
Similarly, MSK embolic microspheres are sought after to
prevent the abnormal overgrowth of blood vessels, a consequence of chronic
inflammation. This kind of inflammation is part of a pathological loop, whereby
the inflammation promotes the formation of new blood vessels that in turn, can
feed nerve growth and contribute to chronic, debilitating pain.2 Microsphere
embolization can therefore be used as a pain management tool, as well. For
applications with this level of weightiness, the microsphere size is a chief
feature.
Together with the form factor, glass microspheres can be
tailored through their composition. First and foremost, any implantable glass
must be compatible with the body. Ancillary to this, the composition can be
altered to offer additional functionality. Using TAE as an example to put this
concept into context, the composition of glass used in this type of application
is unique and important.
TAE is a procedure utilized by interventional radiologists.
Interventional radiology (IR) is the diagnosing and/or treatment of cancer and
other conditions while avoiding major surgery. To achieve this, small tools
such as needles, catheters, or wires are utilized in conjunction with radiation
like MRI, ultrasound, etc. to apply treatment precisely to the tissue site.1–3 Personalization
and optimization of outcomes is a clinical challenge of any medical
intervention, making the accurate delivery and distribution of the embolic
particles in real-time indispensable.
Due to the use of radiation to guide the placement, the
embolic particle should be radiopaque (opaque to radiation) to ensure that
guided delivery to the site can be realized. Compared with glass, this
radiopacity is lacking or more difficult to achieve in microspheres derived
from other material types.
Partner with MO SCI for Precision Glass Microspheres
Each application of glass is unique and therefore may
require unique chemistries and form factors. Glass microspheres are becoming
increasingly popular, since their form factor alone may improve the function of
the glass (depending on the application) when compared to their powder or frit
counterparts.
For applications that require precise microsphere size and
composition, it is important to turn to trusted experts. MO SCI produces a
wide range of glass
microspheres in a variety of chemistries to suit nearly any
need. Contact us today
to learn how glass microspheres may be beneficial for your application.
References
1. Pérez-López
A., et al. (2022). Embolization therapy with microspheres for the treatment of
liver cancer: state-of-the-art of clinical translation. Acta
Biomaterialia. https://doi.org/10.1016/j.actbio.2022.07.019
2. Gremen
E., et al. (2022). Safety and efficacy of embolization with microspheres in
chronic refractory inflammatory shoulder pain: a pilot monocentric study on 15
patients. Biomedicines. https://doi.org/10.3390/biomedicines10040744
3. Kishore
S, et al, (2021). Transarterial embolization for the treatment of chronic
musculoskeletal pain: a systematic review of indications, safety and
efficacy. ACR Open Rheumatology. https://doi.org/10.1002/acr2.11383
MO SCI, LLC
4040 HyPoint North
Rolla, MO 65401
T: 573-364-2338
F: 573-364-9589
Privacy
Policy
Terms & Conditions of Sale
Copyright 2025 MO SCI, LLC
No comments:
Post a Comment